Logo image of BGL

BLUE GOLD LTD-CL A (BGL) Stock Fundamental Analysis

USA - NASDAQ:BGL - KYG1331C1042 - Common Stock

9.83 USD
-0.63 (-6.02%)
Last: 10/10/2025, 9:11:52 PM
9.6071 USD
-0.22 (-2.27%)
After Hours: 10/10/2025, 9:11:52 PM
Fundamental Rating

1

BGL gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 156 industry peers in the Metals & Mining industry. BGL has a bad profitability rating. Also its financial health evaluation is rather negative. BGL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BGL had positive earnings in the past year.
BGL had a negative operating cash flow in the past year.
BGL Yearly Net Income VS EBIT VS OCF VS FCFBGL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 5M 10M

1.2 Ratios

BGL's Return On Assets of 17.46% is amongst the best of the industry. BGL outperforms 97.44% of its industry peers.
BGL has a better Return On Equity (52.85%) than 98.72% of its industry peers.
Industry RankSector Rank
ROA 17.46%
ROE 52.85%
ROIC N/A
ROA(3y)10.96%
ROA(5y)N/A
ROE(3y)22.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BGL Yearly ROA, ROE, ROICBGL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BGL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BGL Yearly Profit, Operating, Gross MarginsBGL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for BGL has been reduced compared to 1 year ago.
BGL has a worse debt/assets ratio than last year.
BGL Yearly Shares OutstandingBGL Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M 25M
BGL Yearly Total Debt VS Total AssetsBGL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 68.07 indicates that BGL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 68.07, BGL belongs to the top of the industry, outperforming 89.10% of the companies in the same industry.
A Debt/Equity ratio of 1.00 indicates that BGL is somewhat dependend on debt financing.
The Debt to Equity ratio of BGL (1.00) is worse than 87.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Altman-Z 68.07
ROIC/WACCN/A
WACCN/A
BGL Yearly LT Debt VS Equity VS FCFBGL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

BGL has a Current Ratio of 0.03. This is a bad value and indicates that BGL is not financially healthy enough and could expect problems in meeting its short term obligations.
BGL's Current ratio of 0.03 is on the low side compared to the rest of the industry. BGL is outperformed by 98.08% of its industry peers.
A Quick Ratio of 0.03 indicates that BGL may have some problems paying its short term obligations.
BGL has a worse Quick ratio (0.03) than 98.08% of its industry peers.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
BGL Yearly Current Assets VS Current LiabilitesBGL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 500K 1M 1.5M 2M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BGL have decreased strongly by -70.84% in the last year.
EPS 1Y (TTM)-70.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 140.43, which means the current valuation is very expensive for BGL.
BGL's Price/Earnings ratio is in line with the industry average.
BGL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.02.
Industry RankSector Rank
PE 140.43
Fwd PE N/A
BGL Price Earnings VS Forward Price EarningsBGL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BGL Per share dataBGL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BGL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLUE GOLD LTD-CL A

NASDAQ:BGL (10/10/2025, 9:11:52 PM)

After market: 9.6071 -0.22 (-2.27%)

9.83

-0.63 (-6.02%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.36%
Inst Owner Change0%
Ins Owners44.39%
Ins Owner ChangeN/A
Market Cap323.60M
AnalystsN/A
Price TargetN/A
Short Float %0.95%
Short Ratio0.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 140.43
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 243.26
P/tB 243.26
EV/EBITDA N/A
EPS(TTM)0.07
EY0.71%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0
BVpS0.04
TBVpS0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 17.46%
ROE 52.85%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)10.96%
ROA(5y)N/A
ROE(3y)22.98%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 68.07
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-70.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y80.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y80.97%
OCF growth 3YN/A
OCF growth 5YN/A